Pale Fire Capital SE »

Heron Therapeutics shares owned by Pale Fire Capital SE

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Pale Fire Capital SE from 13F filings

Historical chart of Pale Fire Capital SE investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Pale Fire Capital SE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Pale Fire Capital SE

Quarter filed Position value Share count Share price at filing
2025-09-30 $594k 471k 1.26

More positions owned by Pale Fire Capital SE

B2gold Corp (BTG)
Groupon Com New (GRPN)
Dole Ord Shs (DOLE)
Iamgold Corp (IAG)
New Gold Inc Cda (NGD)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Centerra Gold (CGAU)
Angi Cl A New (ANGI)
I-80 Gold Corp (IAUX)
Mineralys Therapeutics (MLYS)
J Global (ZD)
Galiano Gold (GAU)
Tsakos Energy Navigation SHS (TEN)
Atai Life Sciences Nv SHS (ATAI)
Liquidia Corporation Com New (LQDA)

View all positions for Pale Fire Capital SE

Top funds holding Heron Therapeutics

Rubric Capital Management
Adage Capital Partners GP
BlackRock
Clearline Capital
Velan Capital Investment Management
Vanguard Group
Palisade Capital Management
Tejara Capital
Baker Bros. Advisors
State Street Corporation
Geode Capital Management
Tang Capital Management
JW Asset Management
D. E. Shaw & Co
UBS Group

View all funds holding Heron Therapeutics